224 related articles for article (PubMed ID: 27229317)
1. NHERF1/EBP50 and NF2 as diagnostic markers for choroid plexus tumors.
Georgescu MM; Mobley BC; Orr BA; Shang P; Lehman NL; Zhu X; O'Neill TJ; Rajaram V; Hatanpaa KJ; Timmons CF; Raisanen JM
Acta Neuropathol Commun; 2016 May; 4(1):55. PubMed ID: 27229317
[TBL] [Abstract][Full Text] [Related]
2. A Comparative Immunohistochemical Study of Epithelial Membrane Antigen and NHERF1/EBP50 in the Diagnosis of Ependymomas.
Nambirajan A; Sharma MC; Rajeshwari M; Kakkar A; Suri V; Sarkar C
Appl Immunohistochem Mol Morphol; 2018 Jan; 26(1):71-78. PubMed ID: 27753657
[TBL] [Abstract][Full Text] [Related]
3. Similar expression pattern of NHERF1 and EZRIN in papillary but not in solid areas of human serous ovarian carcinomas.
Demacopulo B; Lema BE; Cabrini RL; Kreimann EL
Acta Histochem; 2016 Oct; 118(8):797-805. PubMed ID: 27823775
[TBL] [Abstract][Full Text] [Related]
4. Epithelial differentiation with microlumen formation in meningioma: diagnostic utility of NHERF1/EBP50 immunohistochemistry.
Georgescu MM; Olar A; Mobley BC; Faust PL; Raisanen JM
Oncotarget; 2018 Jun; 9(47):28652-28665. PubMed ID: 29983887
[TBL] [Abstract][Full Text] [Related]
5. NHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membrane.
Georgescu MM; Cote G; Agarwal NK; White CL
Neoplasia; 2014 Apr; 16(4):365-74.e1-2. PubMed ID: 24862762
[TBL] [Abstract][Full Text] [Related]
6. NHERF1/EBP50 is an organizer of polarity structures and a diagnostic marker in ependymoma.
Georgescu MM; Yell P; Mobley BC; Shang P; Georgescu T; Wang SH; Canoll P; Hatanpaa KJ; White CL; Raisanen JM
Acta Neuropathol Commun; 2015 Mar; 3():11. PubMed ID: 25775275
[TBL] [Abstract][Full Text] [Related]
7. Roles of NHERF1/EBP50 in cancer.
Georgescu MM; Morales FC; Molina JR; Hayashi Y
Curr Mol Med; 2008 Sep; 8(6):459-68. PubMed ID: 18781953
[TBL] [Abstract][Full Text] [Related]
8. Nuclear expression of NHERF1/EBP50 in Clear Cell Renal Cell Carcinoma.
Lema BE; Patricio GM; Kreimann EL
Acta Histochem; 2021 Jul; 123(5):151717. PubMed ID: 33965858
[TBL] [Abstract][Full Text] [Related]
9. Comparative immunohistochemical study of insulin-like growth factor II and insulin-like growth factor receptor type 1 in pediatric brain tumors.
Ogino S; Kubo S; Abdul-Karim FW; Cohen ML
Pediatr Dev Pathol; 2001; 4(1):23-31. PubMed ID: 11200487
[TBL] [Abstract][Full Text] [Related]
10. A marker for primary choroid plexus neoplasms.
Herbert J; Cavallaro T; Dwork AJ
Am J Pathol; 1990 Jun; 136(6):1317-25. PubMed ID: 2356863
[TBL] [Abstract][Full Text] [Related]
11. NHERF1/EBP50 is a new marker in colorectal cancer.
Hayashi Y; Molina JR; Hamilton SR; Georgescu MM
Neoplasia; 2010 Dec; 12(12):1013-22. PubMed ID: 21170265
[TBL] [Abstract][Full Text] [Related]
12. Ezrin-radixin-moesin (ERM)-binding phosphoprotein 50 organizes ERM proteins at the apical membrane of polarized epithelia.
Morales FC; Takahashi Y; Kreimann EL; Georgescu MM
Proc Natl Acad Sci U S A; 2004 Dec; 101(51):17705-10. PubMed ID: 15591354
[TBL] [Abstract][Full Text] [Related]
13. Dynamic relocalization of NHERF1 mediates chemotactic migration of ovarian cancer cells toward lysophosphatidic acid stimulation.
Oh YS; Heo K; Kim EK; Jang JH; Bae SS; Park JB; Kim YH; Song M; Kim SR; Ryu SH; Kim IH; Suh PG
Exp Mol Med; 2017 Jul; 49(7):e351. PubMed ID: 28684865
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel diagnostic markers for choroid plexus tumors: a microarray-based approach.
Hasselblatt M; Böhm C; Tatenhorst L; Dinh V; Newrzella D; Keyvani K; Jeibmann A; Buerger H; Rickert CH; Paulus W
Am J Surg Pathol; 2006 Jan; 30(1):66-74. PubMed ID: 16330944
[TBL] [Abstract][Full Text] [Related]
15. Choroid plexus tumors differ from metastatic carcinomas by expression of the excitatory amino acid transporter-1.
Beschorner R; Schittenhelm J; Schimmel H; Iglesias-Rozas JR; Herberts T; Schlaszus H; Meyermann R; Wehrmann M
Hum Pathol; 2006 Jul; 37(7):854-60. PubMed ID: 16784985
[TBL] [Abstract][Full Text] [Related]
16. Nuclear NHERF1 expression as a prognostic marker in breast cancer.
Paradiso A; Scarpi E; Malfettone A; Addati T; Giotta F; Simone G; Amadori D; Mangia A
Cell Death Dis; 2013 Nov; 4(11):e904. PubMed ID: 24201803
[TBL] [Abstract][Full Text] [Related]
17. NHERF1: molecular brake on the PI3K pathway in breast cancer.
Georgescu MM
Breast Cancer Res; 2008; 10(2):106. PubMed ID: 18430260
[TBL] [Abstract][Full Text] [Related]
18. Regulation of merlin by protein phosphatase 1-TIMAP and EBP50 in endothelial cells.
Boratkó A; Péter M; Csortos C
Int J Biochem Cell Biol; 2017 Jan; 82():10-17. PubMed ID: 27871951
[TBL] [Abstract][Full Text] [Related]
19. The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy.
Mangia A; Caldarola L; Dell'Endice S; Scarpi E; Saragoni L; Monti M; Santini D; Brunetti O; Simone G; Silvestris N
Cancer Biol Ther; 2015; 16(8):1140-7. PubMed ID: 26126066
[TBL] [Abstract][Full Text] [Related]
20. Notch receptors in human choroid plexus tumors.
Beschorner R; Waidelich J; Trautmann K; Psaras T; Schittenhelm J
Histol Histopathol; 2013 Aug; 28(8):1055-63. PubMed ID: 23479446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]